A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on. The US Food and Drug Administration (FDA) ...

Age-dependent U-shaped trajectories seen for depression and anxiety; symptom levels were significantly higher for survivors ...

As of mid-May, this variant has been identified in nearly 11% of sequenced samples reported worldwide. The WHO has designated this variant as a “variant under monitoring,” and currently assesses the ...

A randomized controlled trial tested the efficacy and safety of a silicone-covered metallic stent compared with a conventional polymeric double-J stent in patients with malignant ureteral obstruction.

Pizza, soup, chicken were top sources of sodium across racial, ethnic groups; top four sources were different for Asian Americans ...

Lymphovascular invasion is a pathologic feature commonly associated with aggressive renal cell carcinoma (RCC) and worse prognosis.

Patients who develop LN within 1 to 5 years after SLE onset may face poorer renal outcomes compared with those who develop the disease earlier.

To better compare belimumab’s efficacy with results from phase 3 trials of obinutuzumab, investigators conducted a post hoc analysis of patients with active proliferative lupus nephritis in the MMF ...

A subset of patients receiving triple immunosuppressive therapy with voclosporin, mycophenolate mofetil, and low-dose glucocorticoids can achieve lower proteinuria targets.

Negotiated reliance may offer a way to provide care to patients who resist efforts by clinicians and healthcare facilities.

The FDA has approved HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood pressure.

The FDA has granted Orphan Drug designation to NS-229 for the treatment of eosinophilic granulomatosis with polyangiitis.